Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Assessment of the efficacy of DC120 minoxidil formulation on hair growth in men with androgenetic alopecia
2014-005573-36Phase 2Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of minoxidil in androgenetic alopecia (AGA) (3 arms), sponsored by Pierre Fabre Laboratories. Primary endpoint: Change in nonvellus target area hair count (TAHC) from baseline to week 16. Started Apr 2015; status: completed.
02
Drugs
minoxidil
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on 2014-005573-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005573-36.